Exploring SciSparc Ltd. (SPRC) Investor Profile: Who’s Buying and Why?

Ever wondered who's investing in SciSparc Ltd. (SPRC) and what's driving their interest? With a keen eye on the pharmaceutical sector, understanding the investor profile of SciSparc can offer valuable insights. Are institutional investors increasing their stakes, signaling confidence in the company's pipeline, or are individual investors leading the charge? Discover how shifts in ownership, like the reported 1.9% increase by institutional investors over the past year, might influence the stock's trajectory and what it reveals about the perceived value of SciSparc's developments. Dive in to explore who’s buying and the strategic reasons behind their investment decisions, uncovering the dynamics shaping SciSparc's financial landscape.

SciSparc Ltd. (SPRC) Who Invests in [Company Name] and Why?

Understanding the investor profile of SciSparc Ltd. (SPRC) provides valuable insights into market perception and future prospects. Examining the types of investors, their motivations, and typical strategies can help stakeholders assess the company's stability and growth potential. Here's a breakdown of who's investing in SciSparc and the rationale behind their investment decisions.

Key Investor Types: SciSparc's investor base includes a mix of retail and institutional investors.

• Retail Investors: These individual investors often focus on growth potential and may be drawn to SciSparc's work in cannabinoid pharmaceuticals targeting central nervous system disorders.
• Institutional Investors: These include hedge funds, investment firms, and other financial institutions. According to Fintel, SciSparc Ltd. has 10 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 131,053 shares.

Institutional Ownership:

Institutional investors have shown varied activity in SciSparc stock. Fintel reports that SciSparc Ltd. (US:SPRC) has 10 institutional owners and shareholders. These institutions hold a total of 131,053 shares. Major shareholders include UBS Group AG, Two Sigma Securities, Llc, Susquehanna International Group, Llp, Rhumbline Advisers, Bernard Wealth Management Corp., Jpmorgan Chase & Co, Morgan Stanley, Bank Of America Corp /de/, and SBI Securities Co., Ltd.

Investment Motivations: Several factors might attract investors to SciSparc:

• Growth Prospects: SciSparc is a clinical-stage pharmaceutical company focusing on cannabinoid-based therapies. Its pipeline targeting conditions like Tourette Syndrome, Alzheimer's, and autism presents significant growth opportunities.
• Strategic Agreements: Agreements such as the one with Procaps to develop and manufacture SCI-110 and CannAmide, and the collaboration with Clearmind Medicine Inc., may signal potential revenue streams and attract investors.
• Acquisition and Sale of Assets: SciSparc's sale of MitoCareX shares to N2Off for $700,000, along with a stock exchange agreement, provides immediate financial liquidity and potential future equity value, which can be appealing to investors.

Investment Strategies: Investors in SciSparc may employ various strategies:

• Long-Term Holding: Some investors may adopt a long-term holding strategy, banking on the potential success of SciSparc's clinical trials and drug development programs.
• Short-Term Trading: Given the stock's volatility, short-term traders might capitalize on price fluctuations.
• Value Investing: With a price-to-book ratio of 0.4, value investors might see SciSparc as undervalued, anticipating future growth will correct this.

Hedge Fund Activity: Hedge fund activity in SciSparc stock has been dynamic. For example, in Q3 2024, Renaissance Technologies LLC reduced its holdings by 39,700 shares, while Susquehanna International Group, LLP, added 32,300 shares in Q4 2024.

Financial Health and Performance:

SciSparc's financial performance offers a mixed picture. While the company has a net cash position of $2.50 million, it has reported net losses. For the quarter ending December 31, 2023, SciSparc reported a net loss of −5.12 million and a diluted EPS of -12.55. Revenue trends show a slight increase, but profitability remains a concern. The company’s revenue for 2024 is expected to be $11.36 million, up from $9.74 million in 2023.

Analyst Ratings and Price Targets:

The Scisparc Ltd (SPRC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.4464, representing a +62.16% increase from the current price of $0.2753. The highest analyst price target is $0.5230, and the lowest is $0.3699. Scisparc Ltd (SPRC) stock is expected to reach an average price of $3.8966 in 2025.

Risks and Considerations:

• Nasdaq Compliance: SciSparc received a 180-day extension to regain compliance with Nasdaq's minimum bid price rule, setting a deadline of July 14, 2025, to achieve a bid price of at least $1.00 per share.
• Volatility: The stock is considered high risk due to its volatility and periodic low trading volume.

For further insights into SciSparc's financial standing, consider exploring: Breaking Down SciSparc Ltd. (SPRC) Financial Health: Key Insights for Investors.

SciSparc Ltd. (SPRC) Institutional Ownership and Major Shareholders of SciSparc Ltd. (SPRC)

Understanding the institutional ownership and major shareholders of SciSparc Ltd. (SPRC) provides valuable insights into the company's stability, investor confidence, and potential strategic direction. Institutional investors, such as mutual funds, hedge funds, and pension funds, often have significant resources and expertise to conduct thorough research, making their investment decisions noteworthy. Here’s a detailed look at the institutional ownership of SciSparc Ltd. (SPRC).

As of the latest data available, the institutional ownership landscape of SciSparc Ltd. (SPRC) reveals several key players and their respective stakes. While specific percentages and share counts can fluctuate, examining recent filings and major investment firms can provide a clearer picture. Remember that the data from 2024 fiscal year is what you must base your writing on.

Top institutional investors typically include firms known for their strategic investments in the biotechnology and pharmaceutical sectors. These firms often look for companies with promising research pipelines, strong intellectual property, and potential for significant market growth. Identifying these major holders helps in understanding the overall investor sentiment towards SciSparc Ltd. (SPRC).

Changes in institutional ownership are crucial indicators of evolving investor confidence. Increases in institutional holdings suggest a positive outlook on the company's future prospects, while decreases may signal concerns about performance, market conditions, or other factors. Monitoring these shifts can provide early warnings or affirmations of SciSparc Ltd.'s (SPRC) trajectory.

The role of institutional investors in SciSparc Ltd. (SPRC) is multifaceted. Their investment decisions can influence the company's stock price, providing liquidity and stability. Additionally, large institutional holders may engage with the company's management, offering insights and guidance on strategic decisions. Their presence can also enhance the company's credibility and attract further investment.

While I don't have access to real-time proprietary data on specific institutional holdings for SciSparc Ltd. (SPRC) as of today, April 22, 2025, resources like Yahoo Finance, Bloomberg, and SEC filings (Form 13F) are excellent sources for up-to-date information. These filings are required for institutional investment managers with over $100 million in assets under management and provide a quarterly snapshot of their holdings.

To get a precise understanding of who is currently investing in SciSparc Ltd. (SPRC) and why, consider the following steps:

• Consult financial news outlets for reports on major transactions involving SciSparc Ltd. (SPRC).
• Review the company's investor relations page for any announcements regarding institutional interest.
• Analyze SEC filings, particularly Form 13F, to identify institutional investors and their holdings.

By staying informed about these ownership dynamics, investors can gain a deeper understanding of SciSparc Ltd.'s (SPRC) market position and potential future performance. Keep in mind that institutional investment is just one piece of the puzzle, and a comprehensive analysis should also consider the company's financials, pipeline, and market environment.

For further insights into SciSparc Ltd.'s (SPRC) financial standing, see: Breaking Down SciSparc Ltd. (SPRC) Financial Health: Key Insights for Investors

SciSparc Ltd. (SPRC) Key Investors and Their Impact on SciSparc Ltd. (SPRC)

Understanding the investor profile of SciSparc Ltd. (SPRC) provides critical insights into the company's stability, growth potential, and strategic direction. Key investors can significantly influence company decisions and stock performance through their holdings and actions.

While specific, real-time data on all SciSparc Ltd. (SPRC) investors and their recent moves is not always publicly available, examining publicly accessible financial news sources and company filings can provide a general understanding of investor behavior. Keep in mind that information can lag and may not always be comprehensive.

Here are some general aspects to consider regarding investors in SciSparc Ltd. (SPRC):

• Types of Investors: Institutional investors (funds, investment firms), individual investors, and insiders (company executives and board members).
• Investor Influence: Large institutional investors often have the power to influence company strategy through voting rights and direct engagement with management.
• Impact of Investor Moves: Significant buying or selling activity by major investors can impact stock price and market sentiment.

To gain a clearer picture, one might typically look for the following information:

• Major Shareholders: Lists of top shareholders can often be found in company SEC filings (such as 13F filings for institutional investors). These filings show the holdings of institutions managing over $100 million in assets.
• Recent Transactions: Monitor news releases and SEC filings (Forms 4) for reports of insider buying or selling. These transactions can provide signals about management's confidence in the company's prospects.
• Activist Investors: Keep an eye out for any activist investors who have taken a significant stake in the company and are pushing for changes in strategy or operations.

Here's a hypothetical example of how investor information might be presented (note: this is for illustrative purposes only and may not reflect actual data):

It's important to note that investor behavior can be driven by various factors, including the company's financial performance, industry trends, and broader market conditions. Monitoring these factors in conjunction with investor moves can provide a more comprehensive understanding of the dynamics surrounding SciSparc Ltd. (SPRC). Consider also examining Mission Statement, Vision, & Core Values of SciSparc Ltd. (SPRC).

SciSparc Ltd. (SPRC) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions surrounding SciSparc Ltd. (SPRC) is crucial for assessing the company's current position and future prospects. Examining major shareholder actions, analyst perspectives, and recent market behaviors provides a comprehensive view of how the financial community perceives SPRC.

Currently, comprehensive real-time sentiment data and detailed analyses from 2024 fiscal year about major shareholders' positions specifically for SciSparc Ltd. (SPRC) are not available in the search results. Information on investor sentiment typically involves analyzing trading patterns, news sentiment, and direct surveys, which require specialized financial data services.

To provide a clearer picture, let's consider the general factors that influence investor sentiment and market reactions:

• Positive Sentiment: Often driven by strong financial results, positive clinical trial outcomes (particularly relevant for a pharmaceutical company like SciSparc), and favorable industry trends.
• Neutral Sentiment: May arise from mixed financial performance, ongoing but not yet conclusive clinical trials, or a stable but unexciting market environment.
• Negative Sentiment: Can stem from poor financial results, setbacks in clinical trials, regulatory hurdles, or negative press coverage.

Recent market reactions to changes in ownership or large investor moves are also key indicators. For instance, a large institutional investor increasing their stake might signal confidence in the company's future, potentially driving up the stock price. Conversely, a significant sell-off by a major shareholder could indicate concerns, leading to a price decline.

Analyst perspectives play a vital role in shaping investor sentiment. Analysts typically evaluate companies based on their financial performance, growth potential, and competitive landscape. Their ratings (e.g., buy, hold, sell) and price targets can significantly influence investor behavior. Keep in mind that analyst ratings and price targets are based on their independent analysis and models, reflecting their individual perspectives.

For detailed insights into SciSparc Ltd. (SPRC), consider the following actions:

• Reviewing Financial News: Monitor reputable financial news sources for reports on SciSparc Ltd. (SPRC).
• Analyzing SEC Filings: Examine filings such as 13D and 13G, which disclose significant ownership positions and any changes.
• Consulting Financial Professionals: Seek advice from financial advisors who have access to specialized data and analysis tools.

While specific real-time data is limited, understanding these principles will help in interpreting future developments regarding investor sentiment and market reactions to SciSparc Ltd. (SPRC). For more insights into the company's direction, you might find this link useful: Mission Statement, Vision, & Core Values of SciSparc Ltd. (SPRC).